<DOC>
	<DOCNO>NCT00005880</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . The use budesonide may effective way prevent bronchial dysplasia . PURPOSE : Randomized double-blinded phase II trial determine effectiveness budesonide treat former current smoker bronchial dysplasia .</brief_summary>
	<brief_title>Budesonide Treating Former Current Smokers With Bronchial Dysplasia</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy inhale budesonide number grade bronchial epithelial dysplastic lesion former current smoker . II . Compare effect inhale budesonide vs placebo modulate several intermediate biomarkers ( i.e. , proliferation , apoptosis , morphometric , methylation marker ) patient population . III . Correlate regression bronchial dysplasia ( number grade ) improvement sputum cytology ( morphometric grade atypical cell ) modulation molecular biomarkers patient population . IV . Compare stability chemopreventive effect treatment regimens six month completion regimens patient . V. Compare safety treatment regimens patient . OUTLINE : This randomize , double-blind , placebo-controlled study . Patients stratify accord gender , smoke status ( current v former ) , morphometric index ( great 3.4 v great 3.4 ) . Patients randomize one two treatment arm . Arm I : Patients receive inhale budesonide twice daily . Arm II : Patients receive inhale placebo twice daily . Treatment continue 6 month absence disease progression unacceptable toxicity . Patients follow 7 month 12 month . PROJECTED ACCRUAL : A total 110 patient ( 55 per treatment arm ) accrue study within 15 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm mild , moderate , severe bronchial dysplasia More one suspicious area abnormal fluorescence bronchoscopy If one abnormal area , lesion must great 1.5 mm Current exsmokers smoke least 30 pack year ( e.g. , 1 pack per day least 30 year ) Sputum cell morphometric index least 7 computerassisted image analysis No invasive cancer bronchoscopy abnormal chest xray suspicious lung cancer PATIENT CHARACTERISTICS : Age : 40 74 Performance status : Not specify Life expectancy : Not specify Hematopoietic : No bleed disorder Hepatic : Not specify Renal : Not specify Cardiovascular : No unstable angina congestive heart failure Pulmonary : No active pulmonary tuberculosis No acute bronchitis pneumonia No acute chronic respiratory failure Other : No history allergy budesonide lactose No know reaction lidocaine Ability reliably take medication Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : At least 6 month since prior oral glucocorticoid ( e.g. , prednisone ) At least 6 month since prior inhale glucocorticoid ( e.g. , budesonide , Beclovent , Becloforte ) Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
</DOC>